Effects of Combined Cognitive Rehabilitation in COPD Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-15

Study Completion Date

2019-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was to examine the effect of endurance training combined with cognitive training in patients with COPD. The intervention group underwent Cognitive Training added to Endurance Training and the control group underwent only Endurance Training.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cognitive Dysfunction in COPD Patients : Role in the Performance of Cognitive-motor Dual Task Situation?

NCT02493790

Chronic Obstructive Pulmonary Disease

COMPLETED

Effectiveness of Different Exercise Training Programs to the Profile of COPD Patients

NCT01336283

Obstructive Chronic Pulmonary Disease Emphysema

COMPLETED PHASE4

Pulmonary Rehabilitation, Dyspnoea and Emotional Cognition in COPD

NCT03092700

COPD Dyspnea Rehabilitation; Tobacco Use +1 more

COMPLETED

Rehabilitation in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD)

NCT01320930

Chronic Obstructive Pulmonary Disease

COMPLETED NA

Comorbidity and Pulmonary Rehabilitation in COPD

NCT03319108

COPD

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pulmonary rehabilitation is an essential part of the management of COPD. Although various methods and therapies of PR have been used in COPD patients. Furthermore, the Cognitive Training has been performed people with mild cognitive impairments.

Therefore, the combination of endurance training and cognitive tarining could be another alternative to improve the exercise tolerance and cognitive function in patients with COPD. It may also be useful for clinicians interested in designing new rehabilitation therapies. The aim of the study was to analyze the effect of CT combined with ET on exercise tolerance and cognitive functions in COPD patient.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endurance Training (ET)

endurance training for control group

Group Type ACTIVE_COMPARATOR

clinical trials

Intervention Type OTHER

examined two type of training on cognitive parameters for COPD patients

ET+cognitive training(CT)

endurance training added to cognitive training for exprimental COPD group

Group Type EXPERIMENTAL

clinical trials

Intervention Type OTHER

examined two type of training on cognitive parameters for COPD patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

clinical trials

examined two type of training on cognitive parameters for COPD patients

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* clinically stable COPD diagnosed by pulmonary function testing (2) absence of heart diseases, severe psychiatric, neurologic or musculoskeletal conditions and /or instable cardiovascular diseases. (3) Absence of medication influencing cognition (4) without history of brain injury, history of stroke or history of alcoholism.